Mutations in MAPT give rise to several different clinical phenotypes, the majority of which are frontotemporal dementia, but which also include Parkinson’s disease dementia, PSP, PD, AD, LBD, CBD, PiD, AGD, and FTD/amyotrophic lateral sclerosis (ALS). This evidence concerns the gene MAPT and Alzheimer disease.